A submission estimated the cost of introducing screening for HCV antibodies at £5.73 million in the first year, with lessening costs subsequently and that it "would add nearly £6 million to the RTCs['] revenue operating costs of approximately £70m pa." Read more about A submission estimated the cost of introducing screening for HCV antibodies at £5.73 million in the first year, with lessening costs subsequently and that it "would add nearly £6 million to the RTCs['] revenue operating costs of approximately £70m pa."
John Canavan wrote a memo to Miss Wheeler regarding the funding of anti-HCV tests. Ortho would not provide free tests for these free trials and as such they would need to be purchased at a total cost of 25,000 oounds . John Canavan was to seek confirmation where these funds would come from. Read more about John Canavan wrote a memo to Miss Wheeler regarding the funding of anti-HCV tests. Ortho would not provide free tests for these free trials and as such they would need to be purchased at a total cost of 25,000 oounds . John Canavan was to seek confirmation where these funds would come from.
Dr Metters wrote a briefing for the Chief Medical Officer, Sir Donald Acheson, informing him of the ACVSB's recommendations and the funding (an estimated £150,000) that would be required for the pilot study. Read more about Dr Metters wrote a briefing for the Chief Medical Officer, Sir Donald Acheson, informing him of the ACVSB's recommendations and the funding (an estimated £150,000) that would be required for the pilot study.
Dr Gunson followed up on the £25,000 grant of funding by writing to Dr Kennedy at the NHS Procurement Directorate submitting a draft protocol for a pilot study in Birmingham, Sheffield and Brentwood. Read more about Dr Gunson followed up on the £25,000 grant of funding by writing to Dr Kennedy at the NHS Procurement Directorate submitting a draft protocol for a pilot study in Birmingham, Sheffield and Brentwood.
Dr Gunson estimated that the annual costs of routine anti-HCV tests on blood donations in England and Wales would amount to (at least) £5,620,000. Read more about Dr Gunson estimated that the annual costs of routine anti-HCV tests on blood donations in England and Wales would amount to (at least) £5,620,000.
The Glasgow RTC, the largest in Scotland, was evaluating the Abbott test. Read more about The Glasgow RTC, the largest in Scotland, was evaluating the Abbott test.
According to John Canavan, the suggestion that assessment of the relative merits of the two tests could have been undertaken concurrently with the implementation of the screening would have raised significant operational considerations for the RTCs in terms of staffing, equipment and donor counselling arrangements. Read more about According to John Canavan, the suggestion that assessment of the relative merits of the two tests could have been undertaken concurrently with the implementation of the screening would have raised significant operational considerations for the RTCs in terms of staffing, equipment and donor counselling arrangements.
Dr Metters wrote to Mike Malone-Lee outlining prior warning of the likely cost if the ACVSB were to recommend introducing Hepatitis C screening for all blood donations. Read more about Dr Metters wrote to Mike Malone-Lee outlining prior warning of the likely cost if the ACVSB were to recommend introducing Hepatitis C screening for all blood donations.
Following a meeting of ACVSB, Dr Metters wrote to Dr Rejman, outlining that it would be far more difficult to demonstrate the practical benefits from the introduction of the Chiron test. Read more about Following a meeting of ACVSB, Dr Metters wrote to Dr Rejman, outlining that it would be far more difficult to demonstrate the practical benefits from the introduction of the Chiron test.
Dr Gunson wrote to Graham Hart, then director of operations of the NHS Management Board in the Department of Health, outlining the development of the Chiron/Ortho test. Read more about Dr Gunson wrote to Graham Hart, then director of operations of the NHS Management Board in the Department of Health, outlining the development of the Chiron/Ortho test.